Stock Price Quote

VEERHEALTH CARE LTD.

NSE : NABSE : 511523ISIN CODE : INE882C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE21.40-0.4 (-1.83 %)
PREV CLOSE ( ) 21.80
OPEN PRICE ( ) 21.37
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 85300
TODAY'S LOW / HIGH ( )21.37 21.40
52 WK LOW / HIGH ( ) 9.3530.1
NSE
This Company is not listed in NSE
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-07 1992
Management Info
Yogesh M Shah - Chairman Bhavin S Shah - Managing Director
Registered Office

Address 629- A, Gazdar House, 1st Floor,Near Kalbadevi Post Office,J. S. S. Marg,
Mumbai,
Maharashtra-400002

Phone 022-22018582

Email info@veerhealthcare.net

Website https://veerhealthcare.net/

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
 Listing : BSE, NSE

NEWS

02Apr NTPC, Tata Motors and SAIL to see some
NTPC has added 3,924 MW power generation capacity in 2023-24, taking the..
02Apr Veerhealth Care surges on getting orde
Veerhealth Care is currently trading at Rs. 22.25, up by 0.47 points or..
01Apr Veerhealth Care gets order worth Rs 57
Veerhealth Care has received order worth Rs 57.36 lakh from Apollo Healt..
21Mar Veerhealth Care informs about analyst
Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and D..
26Feb Veerhealth Care informs about disclosure
Veerhealth Care has informed that it enclosed the disclosure under Regul..
MORE

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit1.9000000000000115.83
Gross Profit 2.34000000000001 11.17
Operating Profit 4.1917.4
Net Sales 28.69132.73
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2542.60 (12.29%)
M.Cap ( in Cr)1570.82
Neuland Laboratories (BSE)
peergroup  7654.80 (1.79%)
M.Cap ( in Cr)9821.02
Mankind Pharma (BSE)
peergroup  2397.40 (5.05%)
M.Cap ( in Cr)96037.07
Sanofi India (BSE)
peergroup  8470.70 (0.89%)
M.Cap ( in Cr)19508.55
Solara Active Pharma (BSE)
peergroup  474.10 (12.15%)
M.Cap ( in Cr)1706.58
MORE

Shareholding Pattern

NON-INSTITUTION 69.59%
PROMOTERS 30.41%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE

About Veerhealth Care Ltd.

Veerhealth Care Ltd. was incorporated in the year 1992. Its today's share price is 21.4. Its current market capitalisation stands at Rs 42.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 132.73 Cr and Total Income of Rs.145.22 Cr. The company's management includes Nilesh Shah, Prakashbhai Shah, Chetan Mehta, Rony Shah, Shruti Shah, Bhavin S Shah, Yogesh M Shah.

It is listed on the BSE with a BSE Code of 511523 , NSE with an NSE Symbol of NIYATILEAS and ISIN of INE882C01035. It's Registered office is at 629- A, Gazdar House, 1st Floor,Near Kalbadevi Post Office,J. S. S. MargMumbai-400002, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Jayesh R Shah & Co, MH Dalal & Associates

download beyond app
download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal BangContact Dp Support Contact Trading Support
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays T+1 Settlement securities
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX HolidaysMCX Data feed product and Charges
Portfolio Management Service (PMS) NBSPL - PMS Disclosure Nirmal Bang PMS - Investor Charter SCORES complaints – March 2024
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Mutual Fund Terms & Conditions Mutual Privacy Policy
NPS NPS Forms and Guidelines NPS-AML Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap Do's And Dont'sInvestor Complaint Data
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Risk Disclosure Grievances NPS Grievance Policy SEBI ScoresRMS Policy Inspection CSR Committee CSR Policy
CSR Activities
FY-2020-2021 FY-2021-2022 FY-2022-2023
Investor Charter
Linked content_Investor Charter for Depositories and DPs Investor Charter for Depositories and DPs Investor Charter for Stock Broker Investor Charter for Research Investor Complaints -RA Investor Complaints-NBEPL
Evoting
NSDL Evoting CDSL Evoting
Client Bank Account list Smartodr Login Investor Grievance Flow Registered AP’sSurrendered List of AP’sKYC Activation Process
Connect with Us
ATTENTION INVESTORS Depository IPO KYC Investor Guide
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL PMS Disclosure Document
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment INZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.